Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Directed reprogramming of comprehensively characterized dental pulp stem cells extracted from natal tooth.

Pisal RV, Suchanek J, Siller R, Soukup T, Hrebikova H, Bezrouk A, Kunke D, Micuda S, Filip S, Sullivan G, Mokry J.

Sci Rep. 2018 Apr 18;8(1):6168. doi: 10.1038/s41598-018-24421-z.

2.

The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance.

Teichroeb JH, Kim J, Betts DH.

RNA Biol. 2016 Aug 2;13(8):707-19. doi: 10.1080/15476286.2015.1134413. Epub 2016 Jan 19. Review.

3.

Blockade of senescence-associated microRNA-195 in aged skeletal muscle cells facilitates reprogramming to produce induced pluripotent stem cells.

Kondo H, Kim HW, Wang L, Okada M, Paul C, Millard RW, Wang Y.

Aging Cell. 2016 Feb;15(1):56-66. doi: 10.1111/acel.12411. Epub 2015 Dec 5.

4.

Transient delivery of modified mRNA encoding TERT rapidly extends telomeres in human cells.

Ramunas J, Yakubov E, Brady JJ, Corbel SY, Holbrook C, Brandt M, Stein J, Santiago JG, Cooke JP, Blau HM.

FASEB J. 2015 May;29(5):1930-9. doi: 10.1096/fj.14-259531. Epub 2015 Jan 22.

5.

Reprogramming suppresses premature senescence phenotypes of Werner syndrome cells and maintains chromosomal stability over long-term culture.

Shimamoto A, Kagawa H, Zensho K, Sera Y, Kazuki Y, Osaki M, Oshimura M, Ishigaki Y, Hamasaki K, Kodama Y, Yuasa S, Fukuda K, Hirashima K, Seimiya H, Koyama H, Shimizu T, Takemoto M, Yokote K, Goto M, Tahara H.

PLoS One. 2014 Nov 12;9(11):e112900. doi: 10.1371/journal.pone.0112900. eCollection 2014.

6.

Adult Stem Cells and Diseases of Aging.

Boyette LB, Tuan RS.

J Clin Med. 2014 Jan 21;3(1):88-134. doi: 10.3390/jcm3010088.

7.

Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogrammed primary prostate cancer cells.

Pollock CB, McDonough S, Wang VS, Lee H, Ringer L, Li X, Prandi C, Lee RJ, Feldman AS, Koltai H, Kapulnik Y, Rodriguez OC, Schlegel R, Albanese C, Yarden RI.

Oncotarget. 2014 Mar 30;5(6):1683-98.

8.

The aging signature: a hallmark of induced pluripotent stem cells?

Rohani L, Johnson AA, Arnold A, Stolzing A.

Aging Cell. 2014 Feb;13(1):2-7. doi: 10.1111/acel.12182. Epub 2013 Nov 21. Review.

9.

Telomere reprogramming and maintenance in porcine iPS cells.

Ji G, Ruan W, Liu K, Wang F, Sakellariou D, Chen J, Yang Y, Okuka M, Han J, Liu Z, Lai L, Gagos S, Xiao L, Deng H, Li N, Liu L.

PLoS One. 2013 Sep 30;8(9):e74202. doi: 10.1371/journal.pone.0074202. eCollection 2013. Erratum in: PLoS One. 2013;8(11). doi:10.1371/annotation/f5e4554b-18cc-46ef-ac39-73ac4d6750ae.

10.

Aging and reprogramming: a two-way street.

Mahmoudi S, Brunet A.

Curr Opin Cell Biol. 2012 Dec;24(6):744-56. doi: 10.1016/j.ceb.2012.10.004. Epub 2012 Nov 9. Review.

11.

Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells.

Wang F, Yin Y, Ye X, Liu K, Zhu H, Wang L, Chiourea M, Okuka M, Ji G, Dan J, Zuo B, Li M, Zhang Q, Liu N, Chen L, Pan X, Gagos S, Keefe DL, Liu L.

Cell Res. 2012 Apr;22(4):757-68. doi: 10.1038/cr.2011.201. Epub 2011 Dec 20.

12.

Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state.

Lapasset L, Milhavet O, Prieur A, Besnard E, Babled A, Aït-Hamou N, Leschik J, Pellestor F, Ramirez JM, De Vos J, Lehmann S, Lemaitre JM.

Genes Dev. 2011 Nov 1;25(21):2248-53. doi: 10.1101/gad.173922.111.

13.

Suppression of the imprinted gene NNAT and X-chromosome gene activation in isogenic human iPS cells.

Teichroeb JH, Betts DH, Vaziri H.

PLoS One. 2011;6(10):e23436. doi: 10.1371/journal.pone.0023436. Epub 2011 Oct 12.

14.

Stem cell transplantation for motor neuron disease: current approaches and future perspectives.

Gowing G, Svendsen CN.

Neurotherapeutics. 2011 Oct;8(4):591-606. doi: 10.1007/s13311-011-0068-7. Review.

15.

Pluripotent stem cell heterogeneity and the evolving role of proteomic technologies in stem cell biology.

Gundry RL, Burridge PW, Boheler KR.

Proteomics. 2011 Oct;11(20):3947-61. doi: 10.1002/pmic.201100100. Epub 2011 Sep 8. Review.

16.

Telomere dynamics in dyskeratosis congenita: the long and the short of iPS.

Agarwal S, Daley GQ.

Cell Res. 2011 Aug;21(8):1157-60. doi: 10.1038/cr.2011.120. Epub 2011 Jul 26. No abstract available.

18.

Association of telomere length with authentic pluripotency of ES/iPS cells.

Huang J, Wang F, Okuka M, Liu N, Ji G, Ye X, Zuo B, Li M, Liang P, Ge WW, Tsibris JC, Keefe DL, Liu L.

Cell Res. 2011 May;21(5):779-92. doi: 10.1038/cr.2011.16. Epub 2011 Feb 1.

19.

Present state and future perspectives of using pluripotent stem cells in toxicology research.

Wobus AM, Löser P.

Arch Toxicol. 2011 Feb;85(2):79-117. doi: 10.1007/s00204-010-0641-6. Epub 2011 Jan 12. Review.

20.

Mitochondrial rejuvenation after induced pluripotency.

Suhr ST, Chang EA, Tjong J, Alcasid N, Perkins GA, Goissis MD, Ellisman MH, Perez GI, Cibelli JB.

PLoS One. 2010 Nov 23;5(11):e14095. doi: 10.1371/journal.pone.0014095.

Supplemental Content

Support Center